Acamprosate has also been approved for the prevention of relapse after detoxification.
If you do not receive an email within 10 minutes, your email address may not be registered,
UFR de Médecine‐Pharmacie de Rouen, Saint Etienne Rouvray, France; UFR de Pharmacie (E.L., M.D.
The aim of this study was to characterize [Please check your email for instructions on resetting your password.
), Universite de Picardie Jules Verne, Amines, France; and Lipha Company (P.D), Lyon, France.1NSERM U 29.5 (M.N., S.H.)
), Universite de Picardie Jules Verne, Amines, France; and Lipha Company (P.D), Lyon, France.Use the link below to share a full-text version of this article with your friends and colleagues.
Although the exact mechanism of action of Acamprosate is not fully understood at the time of this writing, it is thought that, because chronic alcohol abuse alters the balance of certain chemicals in the brain, Acamprosate can restore this balance. Acamprosate is an abstinence-promoting drug widely used in the treatment of alcohol dependence but which has a mechanism of action that has remained obscure for many years.
When it comes to abuse and addiction, there are many types of medication that can help to reduce cravings.
Like naltrexone, the precise mechanism of action of acamprosate is uncertain.
UFR de Médecine‐Pharmacie de Rouen, Saint Etienne Rouvray, France; UFR de Pharmacie (E.L., M.D. However, rather than a standalone treatment, it is used in conjunction with a programme of rehabilitation to enhance the benefits. It can also cause similar characteristics to autism in about a third of sufferers, including social interaction problems.Acamprosate is not classed as an addictive drug and the potential for its abuse is very low.Although the exact mechanism of action of Acamprosate is not fully understood at the time of this writing, it is thought that, because chronic alcohol abuse alters the balance of certain chemicals in the brain, Acamprosate can restore this balance.
Name Starting dosage Dose form Approximate monthly cost* Acamprosate (Campral) Two capsules three times daily.
It helps restore the balance of specific chemicals in the brain that are thought to play a role in the compulsive desire to use alcohol. In 2004, it was approved by the US FDA for use in the treatment of alcohol addiction. Fragile X syndrome is a genetic disorder that causes intellectual disability and distinctive physical features such as large ears, a long narrow face, large testicles, and flexible fingers.
Acamprosate is classified as an alcohol deterrent and a neurotransmitter analogue because it is designed to mimic the action of certain chemicals in the brain, also known as neurotransmitters.
However, the exact mechanism of action of acamprosate is unknown.
UFR de Médecine‐Pharmacie de Rouen, Saint Etienne Rouvray, France; UFR de Pharmacie (E.L., M.D.
We follow strict guidelines when fact-checking information and only use credible sources when citing statistics and medical information. It has been suggested that the anticraving drug, acamprosate, acts via the glutamatergic system, but the exact mechanism of action is still unknown. Then there are others that decrease the pleasurable effects of certain substances, making it less enjoyable to use them.When it comes to detox and rehabilitation, you will be provided with a treatment programme that is designed to fit around you and your requirements. Look for the medically reviewed badge ( If you feel that any of our content is inaccurate or out-of-date, please let us know at This Page was last reviewed and changed on June 23rd, 2020Acamprosate is a medication that is used as part of the treatment of alcohol dependence.
It is important that you tell your doctor about any health problems that you currently have or have had in the past as this could affect the type of medication that you can safely take.Acamprosate is a medication that is used primarily to treat those trying to overcome an alcohol problem.
), Universite de Picardie Jules Verne, Amines, France; and Lipha Company (P.D), Lyon, France.1NSERM U 29.5 (M.N., S.H.)
It is for this reason that it is not recommended for use in those with severe kidney problems.Acamprosate was first synthesised by Lipha and by 1989 was eventually approved for marketing across Europe.
At UKAT, we are committed to provide the most up-to-date and accurate medical information on the web so our readers can make informed decisions about their healthcare. For most people, it can take up to five days before the effects are fully noticeable.Acamprosate is one of two main drugs offered by the NHS for the treatment of alcohol dependence, the other being Disulfiram.The number of prescriptions for Acamprosate dispensed in 2016 was 2.7 times higher than the number of prescriptions for Disulfiram.Acamprosate is 58% cheaper than Disulfiram, which may account for the higher number of prescriptions.